HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease.

Abstract
Alzheimer disease is characterized by extracellular plaques composed of Abeta peptides. We show here that these plaques also contain the serine protease inhibitor neuroserpin and that neuroserpin forms a 1:1 binary complex with the N-terminal or middle parts of the Abeta(1-42) peptide. This complex inactivates neuroserpin as an inhibitor of tissue plasminogen activator and blocks the loop-sheet polymerization process that is characteristic of members of the serpin superfamily. In contrast neuroserpin accelerates the aggregation of Abeta(1-42) with the resulting species having an appearance that is distinct from the mature amyloid fibril. Neuroserpin reduces the cytotoxicity of Abeta(1-42) when assessed using standard cell assays, and the interaction has been confirmed in vivo in novel Drosophila models of disease. Taken together, these data show that neuroserpin interacts with Abeta(1-42) to form off-pathway non-toxic oligomers and so protects neurons in Alzheimer disease.
AuthorsKerri J Kinghorn, Damian C Crowther, Lynda K Sharp, Charlotte Nerelius, Richard L Davis, Howard T Chang, Clare Green, David C Gubb, Jan Johansson, David A Lomas
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 281 Issue 39 Pg. 29268-77 (Sep 29 2006) ISSN: 0021-9258 [Print] United States
PMID16849336 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Neuropeptides
  • Peptides
  • Serpins
  • neuroserpin
  • Trypsin
Topics
  • Alzheimer Disease (metabolism)
  • Amyloid beta-Peptides (chemistry)
  • Animals
  • Biophysical Phenomena
  • Biophysics
  • Drosophila
  • Humans
  • Neuropeptides (chemistry)
  • PC12 Cells
  • Peptides (chemistry)
  • Plaque, Amyloid (metabolism)
  • Protein Binding
  • Protein Structure, Tertiary
  • Rats
  • Serpins (chemistry)
  • Trypsin (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: